PLEC p.Glu2012Lys
c.6034G>A · rs1399422584 · VCV641582
Computational evidence
| Protein change | ||
| AlphaMissense | 0.2349 | likely benign |
|---|---|---|
| REVEL | 0.32 | indeterminate |
| SaProt | — | not scored · why |
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
| Constraint at this position | ||
| Conservation | phyloP 4.8 | phastCons 1 |
| Regional constraint | o/e 1.08 | unconstrained · MANE · 18 kb · p 4.9e-10 · regional, not allelic |
| Overall | ||
| CADD | 24.1 | PHRED · no single calibrated threshold — expert panels disagree |
AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.
⚠ Isoform check: AlphaMissense numbered on a different transcript (AM E2149K vs ClinVar E2012K) — verify the residue.
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| Remaining individualsnot grpmax-eligible | 0.00161% | 62,028 |
| African / African-Americangrpmax | 0.00134% | 74,734 |
| South Asian | 0.0011% | 90,714 |
| European (non-Finnish) | 0.00017% | 589,039 |
Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- PLEC
- Protein
- p.Glu2012Lys
- Coding
- c.6034G>A
- MANE Select
- NM_201384
- dbSNP
- rs1399422584
- Type
- single nucleotide variant
- Location
- chr8:143923895 (GRCh38)
- Gene constraint
- LOEUF 0.726 · pLI <0.01 (gnomAD)
Disease context
epidermolysis bullosa simplex 5A, Ogna type — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsAlso linked: epidermolysis bullosa simplex 5B, with muscular dystrophyepidermolysis bullosa simplex 5C, with pyloric atresiaautosomal recessive limb-girdle muscular dystrophy type 2Qepidermolysis bullosa simplex with nail dystrophy
For PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement (Orphanet):
- Inheritance
- Autosomal dominant
- Onset
- Infancy, Neonatal
Similar variants
- PLEC p.Arg1490Ter Pathogenic/Likely pathogenic ★★ same condition
- PLEC p.Arg1973Trp Pathogenic ★★ ⚠ same condition
- PLEC p.Arg2027Ter Pathogenic ★★ same condition
- PLEC p.Arg2292Ter Pathogenic ★★ same condition
- PLEC p.Arg2324Ter Pathogenic ★★ same condition
- PLEC p.Arg2394Ter Pathogenic ★★ same condition
- PLEC p.Arg559Ter Pathogenic ★★ same condition
- PLEC p.Gln1591Ter Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/plec-p-glu2012lys (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown